Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Collegium Pharmaceutical (COLL) Tax Provisions: 2020-2024

Historic Tax Provisions for Collegium Pharmaceutical (COLL) over the last 5 years, with Dec 2024 value amounting to $56.2 million.

  • Collegium Pharmaceutical's Tax Provisions rose 91.02% to $11.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.4 million, marking a year-over-year decrease of 43.15%. This contributed to the annual value of $56.2 million for FY2024, which is 89.00% up from last year.
  • According to the latest figures from FY2024, Collegium Pharmaceutical's Tax Provisions is $56.2 million, which was up 89.00% from $29.7 million recorded in FY2023.
  • Over the past 5 years, Collegium Pharmaceutical's Tax Provisions peaked at $56.2 million during FY2024, and registered a low of -$74.9 million during FY2021.
  • Over the past 3 years, Collegium Pharmaceutical's median Tax Provisions value was $29.7 million (recorded in 2023), while the average stood at $30.2 million.
  • Per our database at Business Quant, Collegium Pharmaceutical's Tax Provisions crashed by 9,123.01% in 2021 and then soared by 531.77% in 2023.
  • Collegium Pharmaceutical's Tax Provisions (Yearly) stood at $830,000 in 2020, then plummeted by 9,123.01% to -$74.9 million in 2021, then surged by 106.28% to $4.7 million in 2022, then surged by 531.77% to $29.7 million in 2023, then soared by 89.00% to $56.2 million in 2024.